Search details
1.
RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire.
BMC Cancer
; 23(1): 679, 2023 Jul 20.
Article
in English
| MEDLINE | ID: mdl-37468859
2.
Circulating proteins as predictive and prognostic biomarkers in breast cancer.
Clin Proteomics
; 19(1): 25, 2022 Jul 11.
Article
in English
| MEDLINE | ID: mdl-35818030
3.
Multiple functions of the scaffold protein Discs large 5 in the control of growth, cell polarity and cell adhesion in Drosophila melanogaster.
BMC Dev Biol
; 20(1): 10, 2020 06 18.
Article
in English
| MEDLINE | ID: mdl-32552730
4.
Nestin as a Prognostic Biomarker in High-grade Epithelial Ovarian Cancer Treated by Neoadjuvant Chemotherapy.
Anticancer Res
; 42(7): 3583-3594, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35790290
5.
Durable Response to Crizotinib in a Patient with Pulmonary Adenocarcinoma Harboring MET Intron 14 Mutation: A Case Report.
Onco Targets Ther
; 14: 3949-3958, 2021.
Article
in English
| MEDLINE | ID: mdl-34234464
6.
Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor: A case report.
World J Clin Cases
; 9(5): 1139-1147, 2021 Feb 16.
Article
in English
| MEDLINE | ID: mdl-33644178
7.
INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer.
Front Oncol
; 11: 653370, 2021.
Article
in English
| MEDLINE | ID: mdl-34249690
8.
XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer.
F1000Res
; 9: 1219, 2020.
Article
in English
| MEDLINE | ID: mdl-34249349
9.
PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer.
Medicine (Baltimore)
; 99(50): e23418, 2020 Dec 11.
Article
in English
| MEDLINE | ID: mdl-33327268
Results
1 -
9
de 9
1
Next >
>>